Document is current
Any future updates will be listed below
-
Authors
Beckonert, Niklas M. http://orcid.org/0000-0003-3263-369X
Weller, Johannes M.
Alegiani, Anna C.
Boeckh-Behrens, Tobias
Deb-Chatterji, Milani
Hamann, Gerhard F.
Krause, Lars U.
Lehnen, Nils C.
Nitsch, Louisa
Poli, Sven
Riedel, Christian
Tiedt, Steffen
Zweynert, Sarah
Petzold, Gabor C.
Dorn, Franziska
Bode, Felix J.
Berrouschot, J
Bohner, G
Borggrefe, J
Bormann, A
Braun, M
Eckert, B
Ernemann, U
Ernst, MS
Fiehler, J
Gerloff, C
Gröschel, K
Hattingen, J
Henn, KH
Keil, F
Kellert, L
Kraemer, C
Liman, J
Ludolph, A
Muehl-Benninghaus, R
Nikoubashman, O
Nolte, C
Petersen, M
Reich, A
Röther, J
Schäfer, JH
Schell, M
Schellinger, P
Siebert, E
Stögbauer, F
Thomalla, G
Trumm, C
Uphaus, T
Wunderlich, S
,
-
Funding
Funding for this research was provided by:
Universitätsklinikum Bonn
Universitätsklinikum Bonn
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 10 June 2024
First Online: 18 July 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was centrally approved by the institutional review board of the Ludwig-Maximilians University Munich (689–15) and institutional review boards according to local regulations.
: Not applicable.
: NMB received travel grants from Sanofi and Viatris. FD is a consultant/proctor for Cerenovus/Johnson&Johnson, Balt, Cerus Endovascular and Phenox. She received speaker's honoraria from Acandis, Stryker, Cerenovus/Johnson&Johnson, Asahi and research support from Cerenovus/Johnson&Johnson. MDC reports grants from the Werner Otto Stiftung outside the submitted the work. All other authors report no conflicting interests.
